These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35058322)

  • 1. The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging.
    Sutera P; Phillips RM; Deek M; Ozyigit G; Onal C; Tran PT
    J Nucl Med; 2022 Mar; 63(3):339-341. PubMed ID: 35058322
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology.
    Jadvar H
    J Nucl Med; 2018 Sep; 59(9):1338-1339. PubMed ID: 30030344
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
    Lecouvet FE; Oprea-Lager DE; Liu Y; Ost P; Bidaut L; Collette L; Deroose CM; Goffin K; Herrmann K; Hoekstra OS; Kramer G; Lievens Y; Lopci E; Pasquier D; Petersen LJ; Talbot JN; Zacho H; Tombal B; deSouza NM
    Lancet Oncol; 2018 Oct; 19(10):e534-e545. PubMed ID: 30303127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligometastatic prostate cancer treatment.
    Rossetti S; Di Napoli M; Pisano C; C Cecere S; Tambaro R; Ventriglia J; Passarelli A; Iovane G; Feroce F; Lastoria S; Di Gennaro F; Muto P; Borzillo V; Di Franco R; Perdonà S; Quarto G; Pignata S
    Future Oncol; 2021 Oct; 17(29):3893-3899. PubMed ID: 34296622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
    Kim J; Park JS; Ham WS
    Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic prostate cancer: shaping the definition with molecular imaging and an improved understanding of tumor biology.
    Joice GA; Rowe SP; Pienta KJ; Gorin MA
    Curr Opin Urol; 2017 Nov; 27(6):533-541. PubMed ID: 28863016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.
    Nickols NG; Tsai S; Kane N; Tran S; Ghayouri L; Diaz-Perez S; Thein M; Anderson-Berman N; Eason J; Kishan AU; Steinberg ML; Reiter RE; Lee SP; Gin GE; Kwon R; Chang MG; Chao HH; Solanki AA; Sexton R; Lewis M; Lorentz W; Cheung MK; Gage DL; Duriseti S; Valle L; Berenji G; Aronson WJ; Garraway IP; Rettig MB
    Eur Urol; 2024 Aug; 86(2):190-193. PubMed ID: 38490853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oligometastatic prostate cancer. concept and implications.].
    Carrasco Valiente J; Ruiz García JM; Requena Tapia MJ
    Arch Esp Urol; 2018 Mar; 71(3):239-246. PubMed ID: 29633944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligometastatic prostate cancer: The game is afoot.
    Lancia A; Zilli T; Achard V; Dirix P; Everaerts W; Gomez-Iturriaga A; Ingrosso G; Liefhooghe N; Miralbell R; Siva S; Van der Eecken K; Ost P
    Cancer Treat Rev; 2019 Feb; 73():84-90. PubMed ID: 30684842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligometastatic Prostate Cancer: Is it Only a Matter of Perspective?
    Di Lorenzo G; Buonerba C
    Eur Urol; 2019 May; 75(5):705-706. PubMed ID: 30591352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.
    Kothari G; Ost P; Cheung P; Blanchard P; Tree AC; van As NJ; Lo SS; Moghanaki D; Loblaw A; Siva S
    Curr Oncol Rep; 2019 Mar; 21(5):43. PubMed ID: 30919165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oligometastatic prostate cancer management].
    Kleinclauss F; Thiery-Vuillemin A
    Prog Urol; 2019 Jun; 29 Suppl 1():S20-S34. PubMed ID: 31307628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer.
    Gupta A; Pugh TJ; Lam E; Sheridan AD; Nath S
    Oncology (Williston Park); 2019 May; 33(5):187-91. PubMed ID: 31095719
    [No Abstract]   [Full Text] [Related]  

  • 14. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.
    Tosoian JJ; Gorin MA; Ross AE; Pienta KJ; Tran PT; Schaeffer EM
    Nat Rev Urol; 2017 Jan; 14(1):15-25. PubMed ID: 27725639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.
    Farolfi A; Hadaschik B; Hamdy FC; Herrmann K; Hofman MS; Murphy DG; Ost P; Padhani AR; Fanti S
    Eur Urol Oncol; 2021 Oct; 4(5):714-730. PubMed ID: 33750684
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Artigas C; Flamen P; Charlier F; Levillain H; Wimana Z; Diamand R; Albisinni S; Gil T; Velthoven RV; Peltier A; Gestel DV; Roumeguere T; Otte FX
    World J Urol; 2019 Aug; 37(8):1535-1542. PubMed ID: 30824985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is Oligometastatic Prostate Cancer?
    Fraser M; Koontz B; Emmenegger U; De Meerleer G; Khoo V; Feng F; Corcoran NM; Hovens CM; Tran PT; Ost P; Boutros PC;
    Eur Urol Focus; 2019 Mar; 5(2):159-161. PubMed ID: 30642810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate Cancer.
    Murphy DG; Sweeney CJ; Tombal B
    Eur Urol; 2017 Jul; 72(1):1-3. PubMed ID: 28283344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligometastatic prostate cancer: Reality or figment of imagination?
    Foster CC; Weichselbaum RR; Pitroda SP
    Cancer; 2019 Feb; 125(3):340-352. PubMed ID: 30521067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?
    Giannarini G; Fossati N; Gandaglia G; Cucchiara V; Ficarra V; Mirone V; Montorsi F; Briganti A
    Eur Urol; 2018 Aug; 74(2):131-133. PubMed ID: 29625757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.